DV
Dividend Vision

MHIP ETF — Milliman Healthcare Inflation Plus ETF

Milliman Healthcare Inflation Plus ETF (MHIP)

Updated October 16, 2026.

MHIP is an ETF. its expense ratio is 0.55%. Total return is 6.9% over the past 0.5 years, 2.1 points behind SPY at 9.0%.

Milliman Healthcare Inflation Plus ETF is an equity fund that invests in U.S. healthcare companies and healthcare supply chain businesses across all market capitalizations, using a factor-based approach to determine portfolio weights. The fund is non-diversified and does not currently distribute income to shareholders. It carries an expense ratio of 0.55%.

MHIP holdings and sector exposure

Holdings are not available for this snapshot.

MHIP performance versus SPY

Price and return data through 2026-10-16.

Total return is 6.9% over the past 0.5 years, 2.1 points behind SPY at 9.0%.

WindowTotal returnCAGR
1M1.0%—
3M5.7%—
YTD6.9%—
Since inception (0.5 years)6.9%—

MHIP key facts

Issuer
Milliman
Asset type
ETF
Asset class
Equity
Inception date
04/20/2026
Expense ratio
0.55%
Distribution frequency
None
Last close
$21.16 (as of 2026-10-16)
AUM
$1,563,882
Average volume
17.0

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Milliman; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

MHIP risks and drawbacks

Total return has trailed SPY over the available window.

Who may consider MHIP — and who may not

It is a weaker fit for investors who need monthly cash flow (MHIP does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on MHIP

Tagged: Healthcare.

Frequently asked questions

Does MHIP pay monthly?

No. MHIP does not currently distribute.

What is MHIP's expense ratio?

MHIP's expense ratio is 0.55%.

When does MHIP pay a dividend?

MHIP does not currently distribute.

How has MHIP performed?

Total return is 6.9% over the past 0.5 years, 2.1 points behind SPY at 9.0%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.